(Q46353630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Gino A Vena

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Nicoletta Cassano

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Valeria Coco

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

Immunopharmacology and Immunotoxicology

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

447-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Toxic drug-induced chronic pruritus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Postmarketing surveillance of captopril for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Exanthematous reaction to irbesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Hyperbaric oxygen therapy for the management of chronic wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Losartan increases bradykinin levels in hypertensive humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Effects of anti-hypertensive drugs on vessel rarefaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

Human skin: source of and target organ for angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.797992

10.3109/08923973.2013.797992

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23672527%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference